Nebivolol Krka

Nebivolol, the active ingredient in Nebivolol Krka, is a beta blocker presented as an oral tablet for oral use. It is used to treat hypertension in adult patients. GNH USA supplies Nebivolol Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nebivolol is a selective β1‑adrenergic blocker indicated for the management of high blood pressure.

Hypertension: lowers systolic and diastolic blood pressure in adults with essential hypertension. Isolated systolic hypertension: reduces elevated systolic pressure when diastolic values are normal. Diastolic hypertension: helps control high diastolic pressure in patients with isolated diastolic elevation.

Nebivolol may cause a range of adverse reactions, most of which are dose‑related and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Dizziness or light‑headedness, especially on standing. - Fatigue or tiredness during initial therapy. - Nasal congestion or mild upper‑respiratory symptoms. - Gastrointestinal discomfort such as nausea. - Cold extremities due to reduced peripheral perfusion.

Serious or Rare Side Effects: - Bradycardia: markedly reduced heart rate requiring medical attention. - Symptomatic hypotension: severe drop in blood pressure causing faintness. - Heart block or atrioventricular conduction disturbances. - Exacerbation of heart failure in susceptible individuals. - Bronchospasm in patients with reactive airway disease. - Severe allergic reactions such as rash or angioedema.

Before initiating Nebivolol therapy, consider the following safety measures.

Monitor blood pressure: ensure adequate control and avoid excessive hypotension. Assess cardiac function: evaluate for existing bradycardia or heart block. Use caution in asthma or COPD: β‑blockade may worsen bronchospasm. Adjust dose in renal impairment: reduced clearance may require lower dosing. Avoid abrupt discontinuation: taper gradually to prevent rebound hypertension. Store at room temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Nebivolol can interact with several medication classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Other β‑blockers: additive cardiac depression. - Calcium channel blockers (verapamil, diltiazem): increased risk of bradycardia and AV block. - Antiarrhythmic agents (e.g., amiodarone): potentiation of conduction disturbances.

Moderate Interactions (Monitor Closely): - NSAIDs: may blunt antihypertensive effect. - Diuretics: risk of excessive blood pressure reduction. - Other antihypertensives (ACE inhibitors, ARBs): monitor for hypotension. - Antidiabetic drugs: possible enhancement of hypoglycaemic effect.